1-3 of 3
Greta de Jong, MD
Close
Sort by
Journal Articles

Preclinical Development of AT1412, a Patient Derived CD9 Antibody That Does Not Induce Thrombosis for Treatment of B ALL

Remko Schotte, Julien Villaudy, PhD, Greta De Jong, MD, Viviana Neviani, PhD, Wouter Pos, PhD, Sophie E Levie, Daniel M Go, Etsuko Yasuda, PhD, Esmay Frankin, Madalina Cercel, Susan E van Hal-van Veen, Dorien van de Berg, Anikó Szabó, MD, Christien Fatmawati, Martijn Kedde, PhD, Yvonne Claassen, Sjeng Horbach, PhD, Anita W Rijneveld, MD PhD, Piet Gros, prof, Hergen Spits, prof, Mette D Hazenberg, MD PhD, Hans van Eenennaam, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 41–42.
https://doi.org/10.1182/blood-2020-134088
Published: 2020
Journal Articles

Tumor Specific Glycosylated CD43 Is a Novel and Highly Specific Target for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Marijn A. Gillissen, MD, Martijn Kedde, PhD, Greta de Jong, MD, Etsuko Yasuda, PhD, Sophie E. Levie, Arjen Q. Bakker, Marie Jose Kersten, MD PhD, Paul Hensbergen, PhD, Tim Beaumont, PhD, Pauline M. van Helden, PhD, Hergen Spits, PhD, Mette D. Hazenberg, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1646.
https://doi.org/10.1182/blood.V128.22.1646.1646
Published: 2016
Journal Articles

AML Relapse after Rituximab Treatment for Graft-Versus-Host Disease: Crucial Role for B Cells in Graft-Versus-Host and Graft-Versus-Leukemia

Marijn Aletta Gillissen, MD, Sophie E. Levie, Greta de Jong, MD, Etsuko Yasuda, PhD, Arjen Q. Bakker, Pauline M. van Helden, PhD, Douglas M. Jefferson, PhD, Cynthia Huisman, MD PhD, Hergen Spits, PhD, Mette D. Hazenberg, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5473.
https://doi.org/10.1182/blood.V126.23.5473.5473
Published: 2015